Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.
Amplicons are helper-dependent herpes simplex virus type 1 (HSV-1)-based vectors that can deliver very large foreign DNA sequences and, as such, are good candidates both for gene delivery and vaccine development. However, many studies have shown that innate constitutive or induced cellular responses, elicited or activated by the entry of HSV-1 particles, can play a significant role in the control of transgenic expression and in the induction of inflammatory responses. Moreover, transgene expression from helper-free amplicon stocks is often weak and transient, depending on the particular type of infected cells, suggesting that cellular responses could be also responsible for the silencing of amplicon-mediated transgene expression. This review summarizes the current experimental evidence underlying these latter concepts, focusing on the impact on transgene expression of very-early interactions between amplicon particles and the infected cells, and speculates on possible ways to counteract the cellular protective mechanisms, thus allowing stable transgene expression without enhancement of vector toxicity.
Tsitoura
Eliza
E
Université de Lyon, Lyon, F-69003, France; CNRS, UMR5534, Centre de Génétique Moléculaire et Cellulaire, Villeurbanne, F-69622, France.
Epstein
Alberto L
AL
J Virol. 1989 Nov;63(11):4479-88
2552134
Bioessays. 2000 Aug;22(8):761-70
10918307
J Gen Virol. 2006 May;87(Pt 5):1099-1108
16603509
Immunobiology. 2007;212(9-10):877-86
18086386
Mol Ther. 2009 Apr;17(4):707-15
19223864
J Gene Med. 2005 Sep;7(9):1187-99
15852412
J Virol. 1996 Oct;70(10):7190-7
8794366
J Virol. 2006 Apr;80(7):3293-300
16537596
Virol J. 2008 Nov 21;5:140
19025601
J Gene Med. 2008 Feb;10(2):152-64
18058952
Blood. 2009 Apr 2;113(14):3264-75
18952891
Oncogene. 1999 Jan 28;18(4):935-41
10023669
Hum Gene Ther. 1998 Dec 10;9(18):2787-94
9874276
J Virol. 2000 Dec;74(24):11782-91
11090178
J Virol. 2004 Feb;78(4):1675-84
14747533
Expert Opin Biol Ther. 2007 Jul;7(7):975-95
17665988
Virology. 2005 Jun 5;336(2):274-90
15892968
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10410-5
11517326
Virology. 2001 Nov 10;290(1):115-20
11882996
J Gen Virol. 2003 Jan;84(Pt 1):1-15
12533696
J Virol. 2002 Feb;76(4):1995-8
11799195
J Virol. 2002 Jan;76(2):743-54
11752164
J Virol. 1991 Dec;65(12):7046-50
1658396
J Virol. 1996 Sep;70(9):6358-69
8709264
J Virol. 2008 Mar;82(6):2661-72
18160441
J Virol. 2004 Feb;78(4):1763-74
14747541
Virol J. 2006 Jun 09;3:44
16764725
J Virol. 2008 May;82(10):4688-96
18321964
J Virol. 2001 Oct;75(19):8977-86
11533161
Science. 1994 Nov 25;266(5189):1399-403
7669103
Virology. 2004 Feb 20;319(2):212-24
14980482
J Biol Chem. 2009 Jan 9;284(2):1097-105
19010780
Science. 2000 Feb 25;287(5457):1500-3
10688801
J Immunol. 2001 Oct 1;167(7):3928-35
11564811
J Immunol. 1997 Feb 15;158(4):1763-71
9029114
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9583-7
8790373
J Biol Chem. 2003 Sep 19;278(38):36059-67
12844494
Gene Ther. 2003 Aug;10(17):1437-45
12900758
J Virol. 2004 Dec;78(24):13582-90
15564469
J Virol. 2004 Sep;78(18):10193-6
15331752
Nat Biotechnol. 2001 Nov;19(11):1067-70
11689853
J Virol. 2002 Mar;76(5):2180-91
11836395
J Virol. 1999 Apr;73(4):2803-13
10074128
Cell Host Microbe. 2007 Mar 15;1(1):23-35
18005679
EMBO Rep. 2006 Sep;7(9):911-8
16906131
J Virol. 2007 Apr;81(7):3455-64
17229694
Cell. 1982 Aug;30(1):295-304
6290080
Mol Ther. 2001 Apr;3(4):591-601
11319922
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
9023344
Cell. 1994 May 20;77(4):525-35
8187174
Mol Ther. 2003 May;7(5 Pt 1):604-12
12718903
Gene Ther. 1998 Nov;5(11):1517-30
9930305
Blood. 2001 Jul 15;98(2):287-95
11435295
J Virol. 2003 Jun;77(12):7101-5
12768029
Mol Ther. 2007 Feb;15(2):248-54
17235301
Mol Ther. 2003 Feb;7(2):218-27
12597910
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7891-6
9223283
EMBO J. 2002 Sep 16;21(18):4989-97
12234938
J Virol. 1998 Nov;72(11):8620-6
9765401
J Gen Virol. 2004 Dec;85(Pt 12):3501-3510
15557223
J Virol. 2008 May;82(10):4974-90
18337577
J Virol. 2006 Aug;80(16):7995-8005
16873256
J Gen Virol. 2009 Sep;90(Pt 9):2209-20
19515829
J Neurovirol. 2002 Dec;8 Suppl 2:103-11
12491160
Virology. 2004 Apr 25;322(1):158-67
15063125
Mol Ther. 2008 Oct;16(10):1727-36
18728642
Mol Ther. 2007 Nov;15(11):2017-26
17653098
Hum Gene Ther. 2003 Jul 20;14(11):1049-63
12885345
Hum Gene Ther. 2007 Feb;18(2):93-105
17298238
J Virol. 2003 Jun;77(11):6567-73
12743316
Nature. 1984 Jun 14-20;309(5969):633-5
6328323
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7571-6
15897453
Virology. 2008 May 10;374(2):487-94
18279905